Faltas BM - Search Results

1

Circulating and urinary tumour DNA in urothelial carcinoma - upper tract, lower tract and metastatic disease.

Rose KM, Huelster HL, Meeks JJ, Faltas BM, Sonpavde GP, Lerner SP, Ross JS, Spiess PE, Grass GD, Jain RK, Kamat AM, Vosoughi A, Wang L, Wang X, Li R. Rose KM, et al. Among authors: faltas bm. Nat Rev Urol. 2023 Jul;20(7):406-419. doi: 10.1038/s41585-023-00725-2. Epub 2023 Mar 28. Nat Rev Urol. 2023. PMID: 36977797 Review.

2

Application of next-generation sequencing in gastrointestinal and liver tumors.

Mikhail S, Faltas B, Salem ME, Bekaii-Saab T. Mikhail S, et al. Cancer Lett. 2016 May 1;374(2):187-91. doi: 10.1016/j.canlet.2016.02.029. Epub 2016 Feb 23. Cancer Lett. 2016. PMID: 26916979 Review.

3

A new anticoagulant for a new era: review of recent data on dabigatran etexilate.

Faltas B. Faltas B. Clin Adv Hematol Oncol. 2010 Oct;8(10):697-702. Clin Adv Hematol Oncol. 2010. PMID: 21317868 Review.

4

Update on perioperative bridging in patients on chronic oral anticoagulation.

Faltas B, Kouides PA. Faltas B, et al. Expert Rev Cardiovasc Ther. 2009 Dec;7(12):1533-9. doi: 10.1586/erc.09.128. Expert Rev Cardiovasc Ther. 2009. PMID: 19954315 Review.

5

Targeting hematogenous spread of circulating tumor cells by a chemotactic drug-eluting IVC filter to prevent pulmonary and systemic metastasis.

Faltas B. Faltas B. Med Hypotheses. 2010 Apr;74(4):668-9. doi: 10.1016/j.mehy.2009.11.008. Epub 2009 Dec 23. Med Hypotheses. 2010. PMID: 20031338

6

Prolonged and increased postoperative risk of venous thromboembolism: rationale for even more 'extended' prophylaxis?

Faltas B. Faltas B. Expert Rev Hematol. 2010 Apr;3(2):161-3. doi: 10.1586/ehm.10.6. Expert Rev Hematol. 2010. PMID: 21083460

7

The Cytidine Deaminase APOBEC3G Contributes to Cancer Mutagenesis and Clonal Evolution in Bladder Cancer.

Liu W, Newhall KP, Khani F, Barlow L, Nguyen D, Gu L, Eng K, Bhinder B, Uppal M, Récapet C, Sboner A, Ross SR, Elemento O, Chelico L, Faltas BM. Liu W, et al. Among authors: faltas bm. Cancer Res. 2023 Feb 15;83(4):506-520. doi: 10.1158/0008-5472.CAN-22-2912. Cancer Res. 2023. PMID: 36480186

8

Can't catch a breath.

Faltas B, Chow MY. Faltas B, et al. Am J Med. 2007 Sep;120(9):778-80. doi: 10.1016/j.amjmed.2007.05.002. Am J Med. 2007. PMID: 17765046 No abstract available.

9

Characterization of metastatic urothelial carcinoma via comprehensive genomic profiling of circulating tumor DNA.

Agarwal N, Pal SK, Hahn AW, Nussenzveig RH, Pond GR, Gupta SV, Wang J, Bilen MA, Naik G, Ghatalia P, Hoimes CJ, Gopalakrishnan D, Barata PC, Drakaki A, Faltas BM, Kiedrowski LA, Lanman RB, Nagy RJ, Vogelzang NJ, Boucher KM, Vaishampayan UN, Sonpavde G, Grivas P. Agarwal N, et al. Among authors: faltas bm. Cancer. 2018 May 15;124(10):2115-2124. doi: 10.1002/cncr.31314. Epub 2018 Mar 8. Cancer. 2018. PMID: 29517810 Free PMC article.

10

Treatment resistance in urothelial carcinoma: an evolutionary perspective.

Vlachostergios PJ, Faltas BM. Vlachostergios PJ, et al. Among authors: faltas bm. Nat Rev Clin Oncol. 2018 Aug;15(8):495-509. doi: 10.1038/s41571-018-0026-y. Nat Rev Clin Oncol. 2018. PMID: 29720713 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

97 results

Search Page